-+ 0.00%
-+ 0.00%
-+ 0.00%

ImmunityBio Survey Finds 63% of Military Bladder Cancer Patients Face Treatment Barriers

PUBT·11/11/2026 13:31:54
Listen to the news
ImmunityBio Survey Finds 63% of Military Bladder Cancer Patients Face Treatment Barriers
  • ImmunityBio released results from a national survey of military service members and veterans with non-muscle invasive bladder cancer.
  • Respondents faced significant barriers to treatment, including delays in care and difficulty accessing recommended treatments.
  • Respondents reported strong trust in their healthcare providers despite these challenges.
  • The findings highlighted demand for more treatment options and resources to help veterans navigate care.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611110830BIZWIRE_USPR_____20261111_BW272974) on November 11, 2026, and is solely responsible for the information contained therein.